# Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma

> **NCT05626829** · PHASE2 · UNKNOWN · sponsor: **Jian Guan** · enrollment: 18 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma
- Recurrent Cancer

## Interventions

- **DRUG:** Tranilast

## Key facts

- **NCT ID:** NCT05626829
- **Lead sponsor:** Jian Guan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-20
- **Primary completion:** 2024-07-20
- **Final completion:** 2024-11-30
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2023-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05626829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05626829, "Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT05626829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*